Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044975 · ClinicalTrials.gov registry record · NA
Improving Sleep in Gynecologic Cancer Survivors
A NA study of Sleep Disturbance and Gynecologic Cancer, sponsored by University of Arizona.
- Active
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 2
- Study locations
NCT05044975: Active NA study of Sleep Disturbance and Gynecologic Cancer, sponsored by University of Arizona.
NCT05044975 is a NA study of Sleep Disturbance and Gynecologic Cancer that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 95 participants, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (46% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05044975, a NA study of Sleep Disturbance and Gynecologic Cancer, is active but no longer recruiting, sponsored by University of Arizona.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 2
- Study locations
Study Summary
This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.
Primary Outcome
Wrist actigraphy
Conditions Studied
Interventions
- BEHAVIORAL Sleep restriction
- BEHAVIORAL Stimulus control
- BEHAVIORAL Systematic light exposure
Study Locations (2)
Arizona
- University of Arizona College of Nursing - Tucson
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT05044975 still lists
NCT05044975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (46% lower).
The record links to 2 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 3 interventions - of which Sleep restriction is the first listed.
NCT05044975 reports a single indexed study location in Arizona, Illinois.
Frequently Asked Questions
What is clinical trial NCT05044975 about?
NCT05044975 is a clinical study titled "Improving Sleep in Gynecologic Cancer Survivors". This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.
What is the current status of trial NCT05044975?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2021-10-11. Estimated completion is 2026-01-31.
What conditions does trial NCT05044975 study?
This clinical trial studies the following conditions: Sleep Disturbance, Gynecologic Cancer.
What interventions are being tested in trial NCT05044975?
The interventions under investigation include: Sleep restriction (BEHAVIORAL), Stimulus control (BEHAVIORAL), Systematic light exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT05044975?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05044975 being conducted?
This trial has 2 study locations across Arizona, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05044975's enrollment target sits among peer trials
95 28th of 56 higher than 29 of 56 other Sleep Disturbance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disturbance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adjunctive Bright Light Therapy for Opioid Use Disorder
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
RECRUITING · NA
-
Sleep Promotion Program Primary Care
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
SPARK Healthy Sleep
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI